Biomarin Pharmaceutical Inc (BMRN)
66.60
+0.71
(+1.08%)
USD |
NASDAQ |
Nov 01, 16:00
66.60
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Profit Margin (Quarterly): 14.22% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.22% |
| June 30, 2024 | 15.05% |
| March 31, 2024 | 13.66% |
| December 31, 2023 | 3.15% |
| September 30, 2023 | 6.95% |
| June 30, 2023 | 9.41% |
| March 31, 2023 | 8.53% |
| December 31, 2022 | -0.05% |
| September 30, 2022 | -1.32% |
| June 30, 2022 | 5.18% |
| March 31, 2022 | 23.26% |
| December 31, 2021 | -12.87% |
| September 30, 2021 | -8.93% |
| June 30, 2021 | 2.58% |
| March 31, 2021 | 3.57% |
| December 31, 2020 | 3.77% |
| September 30, 2020 | |
| June 30, 2020 | -6.79% |
| March 31, 2020 | 16.21% |
| December 31, 2019 | 3.31% |
| September 30, 2019 | 11.94% |
| June 30, 2019 | -9.65% |
| March 31, 2019 | -14.09% |
| December 31, 2018 | -1.03% |
| September 30, 2018 | -3.22% |
| Date | Value |
|---|---|
| June 30, 2018 | -4.50% |
| March 31, 2018 | -11.82% |
| December 31, 2017 | -14.34% |
| September 30, 2017 | -3.75% |
| June 30, 2017 | -11.60% |
| March 31, 2017 | -5.36% |
| December 31, 2016 | -30.23% |
| September 30, 2016 | -13.37% |
| June 30, 2016 | -139.6% |
| March 31, 2016 | -35.08% |
| December 31, 2015 | 30.10% |
| September 30, 2015 | -43.53% |
| June 30, 2015 | -32.78% |
| March 31, 2015 | -33.26% |
| December 31, 2014 | -30.34% |
| September 30, 2014 | 4.22% |
| June 30, 2014 | -17.47% |
| March 31, 2014 | -25.15% |
| December 31, 2013 | -42.21% |
| September 30, 2013 | -38.74% |
| June 30, 2013 | -15.74% |
| March 31, 2013 | -31.12% |
| December 31, 2012 | -40.18% |
| September 30, 2012 | -4.18% |
| June 30, 2012 | -25.81% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.87%
Minimum
Dec 2021
23.26%
Maximum
Mar 2022
5.21%
Average
3.77%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 18.95% |
| Bristol-Myers Squibb Co | 10.18% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Bioventus Inc | -15.87% |
| Moderna Inc | -578.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.29% |
| Return on Assets | 4.69% |
| Return on Invested Capital | 5.27% |
| Gross Profit Margin (Quarterly) | 74.73% |
| Operating Margin (Quarterly) | 15.27% |
| Return on Net Operating Assets | 8.77% |